Multi-Dose Diquafosol Sodium Stare Drops Obtained Approval from NMPA for Commercialisation in China

HONG KONG, July 25, 2025 – (ACN Newswire) – Essex Bio-Expertise Puny (“Essex” or the “Neighborhood”, Stock Code: 1061.HK) is delighted to insist that (Zhuhai Essex Bio-Pharmaceutical Firm Puny), an indirect wholly-owned subsidiary, has received approval from (National Clinical Merchandise Administration) for the registration and commercialisation of the multi-dose Diquafosol Sodium Stare Drops within the PRC.The Current Product is a multi-dose leer tumble components containing 3% diquafosol sodium (5ml:150mg…
Be taught More